Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Jing Xian und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Phytochemicals. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 244 Literaturangaben. Gefördert von: State Administration of Traditional Chinese Medicine of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Obesity is a metabolic disorder that has become a global health concern. The existing pharmaceutical drugs for treating obesity have some side effects. Compounds from natural sources are prospective substitutes for treating chronic diseases such as obesity, with the added advantages of being safe and cost‐effective. However, due to factors such as poor solubility, low bioavailability, and instability in the physiological environment, the therapeutic efficacy of phytoconstituents is limited. Nowadays, developing nanoscaled systems has emerged as a vital strategy for enhancing the delivery and therapeutic effect of phytoconstituents. The present study discusses and categorizes phytoconstituents with anti‐obesity effects and concludes the main mechanisms underlying their effects. Importantly, strategies used to develop phytoconstituent‐based nano‐drug delivery systems (NDDS) for obesity treatment that show improved efficacy relative to traditional administration routes are reviewed. Finally, the progress of research on phytoconstituent‐based NDDS for obesity treatment is summarized to provide a reference for the development of safe and effective treatment strategies for obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
- Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China.
ORCID-Profile: Jingjing Li, Jinming Zhang
Förderung
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Xian, J., Huang, Y., Bai, J., Liao, Q., Chen, Q., Cheng, W., Su, Z., Li, S., Wu, Y., Li, J., & Zhang, J. (2025). Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems. Phytotherapy Research. https://doi.org/10.1002/ptr.8400
Vancouver
Xian J, Huang Y, Bai J, Liao Q, Chen Q, Cheng W, et al. Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems. Phytotherapy Research. 2025. doi:10.1002/ptr.8400
BibTeX
@article{Xian2025,
author = {Xian, Jing and Huang, Yu and Bai, Jinrong and Liao, Qian and Chen, Qiyan and Cheng, Weijian and Su, Ziye and Li, Siyao and Wu, Yihan and Li, Jingjing and Zhang, Jinming},
title = {Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8400}
}
EUVIMED